BRAINSTORM CELL THERAPEUTICS - COM NEW (BCLI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q1 2025

Type / Class
Equity / COM NEW
Symbol
BCLI on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BRAINSTORM CELL THERAPEUTICS - COM NEW (BCLI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$87,188 0
2024 Q4 38,409 $87,188 -$3,549,899 $2.27 3
2024 Q3 10,822,351 $2,486,573 -$330,765 $0.23 33
2024 Q2 12,052,406 $4,079,750 +$2,711,831 $0.34 44
2024 Q1 3,881,982 $2,192,251 +$82,765 $0.56 44
2023 Q4 3,801,492 $1,039,173 -$159,214 $0.27 44
2023 Q3 4,633,811 $928,378 -$3,135,364 $0.20 51
2023 Q2 5,566,349 $11,465,910 -$1,685,190 $2.06 56
2023 Q1 6,175,059 $20,377,818 +$8,169,569 $3.30 46
2022 Q4 3,670,236 $6,016,884 -$246,998 $1.64 41
2022 Q3 3,868,555 $17,122,609 +$95,542 $4.42 37
2022 Q2 3,947,234 $10,888,005 -$598,006 $2.76 41
2022 Q1 4,137,505 $15,189,616 -$1,122,179 $3.36 35
2021 Q4 4,399,937 $17,591,924 -$2,477,237 $4.00 38
2021 Q3 5,131,323 $16,931,897 -$1,754,628 $3.30 48
2021 Q2 5,626,237 $21,385,888 -$10,535,132 $3.80 53
2021 Q1 8,396,793 $32,140,271 -$25,813 $3.83 69
2020 Q4 8,191,672 $37,098,109 -$1,046,879 $4.53 84
2020 Q3 6,796,202 $114,938,774 +$11,549,832 $16.92 77
2020 Q2 6,244,123 $69,990,576 +$28,799,797 $11.21 73
2020 Q1 3,694,659 $17,120,545 +$7,570,023 $4.64 49
2019 Q4 2,067,245 $8,846,425 -$184,521 $4.28 41
2019 Q3 2,114,669 $8,236,299 +$704,913 $3.90 38
2019 Q2 1,927,347 $7,608,315 -$1,941,997 $3.95 35
2019 Q1 2,412,638 $10,468,445 -$161,185 $4.34 37
2018 Q4 2,449,439 $8,688,533 +$244,724 $3.55 33
2018 Q3 2,366,781 $9,038,573 -$256,350 $3.82 32
2018 Q2 2,433,848 $9,479,585 +$3,269,998 $3.90 34
2018 Q1 1,677,309 $5,284,473 -$549,709 $3.15 32
2017 Q4 1,819,386 $7,109,835 +$707,240 $3.91 34
2017 Q3 1,630,493 $6,713,928 -$2,460,693 $4.12 31
2017 Q2 2,389,645 $9,223,000 +$4,965,504 $4.15 23
2017 Q1 1,025,369 $4,353,000 -$800,196 $4.24 24
2016 Q4 1,550,031 $3,938,000 +$609,384 $2.54 26
2016 Q3 1,311,812 $3,139,000 -$766,851 $2.40 23
2016 Q2 1,629,097 $3,928,000 -$177,461 $2.41 21
2016 Q1 1,693,610 $4,520,000 +$523,605 $2.68 25
2015 Q4 1,494,956 $4,277,000 -$986,346 $2.86 21
2015 Q3 1,918,254 $4,394,000 +$244,904 $2.29 19
2015 Q2 1,794,505 $6,481,000 -$2,294,804 $3.62 19
2015 Q1 2,407,922 $10,712,000 +$10,257,636 $4.45 20
2014 Q4 102,351 $487,000 -$3,289,580 $4.76 9
2014 Q3 917,450 $3,776,000 +$3,776,000 $4.18 7